Lulibor Lotion contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The lotion formulation allows for easy application and rapid absorption into the affected skin areas, promoting effective antifungal activity. Lulibor Lotion is typically applied once daily to the clean, dry affected area and surrounding skin for a duration prescribed by a healthcare professional, usually ranging from one to two weeks depending on the severity and type of infection. It is well tolerated, with minimal adverse effects; however, mild local reactions such as burning, itching, or irritation may occasionally occur. Lulibor Lotion should be used with caution in patients with known hypersensitivity to luliconazole or any of the formulation excipients. It is not intended for use on mucous membranes or in the eyes. Proper adherence to the treatment regimen is essential to ensure complete resolution of infection and to prevent recurrence.